Ongoing research aims to identify the factors associated with the development of specific CHIP clones and progression of pre-existing clones (e.g., genotoxic therapies or smoking), in order to develop the appropriate preventive strategies for individuals at high risk of AML and MDS [77,78]. Here, STUB1 is linked to acute myeloid leukemia.